Menu Back to Committee

Program Committee

  • Teresa  Ancukiewicz, MA
    Teresa Ancukiewicz, MA Senior Manager, Clinical Data Management
    Boston Scientific Corporation, United States
  • Kimberly  Belsky, MS
    Kimberly Belsky, MS Senior Director, Regulatory Affairs, Regulatory Intelligence
    Mallinckrodt Pharmaceuticals, United States
  • Larry A. Blankstein, PhD
    Larry A. Blankstein, PhD Consultant, Clinical Development
    Blankstein Consulting Group, United States
  • Daniel M. Bollag, PhD
    Daniel M. Bollag, PhD Senior Vice President, Regulatory Affairs and Quality
    Ariad Pharmaceuticals Inc., United States
  • Linda F. Bowen, MSc, RAC
    Linda F. Bowen, MSc, RAC US Regulatory Science and Policy
    Sanofi, United States
  • Bill  Byrom, PhD
    Bill Byrom, PhD Senior Director of Product Innovation, and Vice Director of ePRO Consortium
    ICON Clinical Research, United Kingdom
  • Joy A. Cavagnaro
    Joy A. Cavagnaro President
    Access BIO, United States
  • Dannis Y. Chang, PharmD
    Dannis Y. Chang, PharmD Medical Science Director, Cancer Immunotherapy, US Medical Affairs
    Genentech, A Member of the Roche Group, United States
  • Karla  Childers, MS
    Karla Childers, MS Senior Director, Strategic Projects, Office of the Chief Medical Officer
    Johnson & Johnson, United States
  • Leah  Christl, PhD
    Leah Christl, PhD Associate Director for Therapeutic Biologics, TBBS, OND, CDER
    FDA, United States
  • Brenda  Crowe, PhD
    Brenda Crowe, PhD Senior Research Advisor, Global Statistical Sciences
    Eli Lilly and Company, United States
  • Sara  Doshi, PharmD
    Sara Doshi, PharmD Director, Medical Information Strategy and Capabilities, GMI
    Eli Lilly and Company, United States
  • Betsy  Fallen, RN
    Betsy Fallen, RN Consultant
    Bafallen Consulting LLC, United States
  • Barbara  Gladson, PhD, MS
    Barbara Gladson, PhD, MS Director of Biopharma Initiative; Interim Chair, Health Infomatics
    Rutgers School of Health Professions , United States
  • Richard  Gliklich, MD
    Richard Gliklich, MD Chief Executive Officer
    OM1, Inc., United States
  • Jonathan  Haddad
    Jonathan Haddad Director, Clinical Statistics
    GlaxoSmithKline, United States
  • Martin  Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM Principal International Affairs Officer
    European Medicines Agency, European Union, United Kingdom
  • Jonathan Solomon Helfgott, MS
    Jonathan Solomon Helfgott, MS Coordinator for Regulatory Science Program
    Johns Hopkins University, United States
  • Frank  Hubbard, PhD
    Frank Hubbard, PhD President
    Global Regulatory Writing Solutions, Inc., United States
  • Virginia  Hussong
    Virginia Hussong Data Standards Program Manager, OD, BSS, CBER
    FDA, United States
  • Nita  Ichhpurani, PMP
    Nita Ichhpurani, PMP Senior Director, External Study Management, Drug Development Services
    Celerion, Canada
  • John  Kamp
    John Kamp Executive Director
    Coalition For Healthcare Communication, United States
  • Sean Y. Kassim, PhD
    Sean Y. Kassim, PhD Director, Office of Study Integrity and Surveillance, OTS, CDER
    FDA, United States
  • Ellen  Kelso
    Ellen Kelso Knowledge Sharing and Engagement, Ltd.
    Consultant, United States
  • Lisa Palladino Kim, MS
    Lisa Palladino Kim, MS Director of Capstone / Lecturer
    Rutgers, The State University of New Jersey, United States
  • Lynn  King, MHA
    Lynn King, MHA Senior Director, Clinical Operations
    TKL Research, Inc., United States
  • Agnes V. Klein, DrPH, MD
    Agnes V. Klein, DrPH, MD Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products
    Health Canada, Canada
  • Stephen  Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP Senior Director, Global Patient Safety, Medical and Benefit Risk Management
    Eli Lilly and Company, United States
  • Mark A. Kryah, PMP
    Mark A. Kryah, PMP Sr Advisor/COO, Bio-Medicines Business Unit
    Eli Lilly and Company, United States
  • Andrea C. Masciale, JD
    Andrea C. Masciale, JD Vice President, Regulatory Policy and Global Analytics
    Johnson & Johnson, United States
  • Ann  Meeker-O'Connell, MS
    Ann Meeker-O'Connell, MS Senior Director/ Head, BioResearch Quality and Compliance, Consumer Products
    Johnson & Johnson, United States
  • Mary Stober Murray, MBA
    Mary Stober Murray, MBA Associate Director, Diversity and Patient Engagement
    Bristol-Myers Squibb Company, United States
  • Bob  Muzerall
    Bob Muzerall Vice President, Sales & Sales Training
    AMPLEXOR Life Sciences, LLC, United States
  • Jane E. Myles, MS
    Jane E. Myles, MS Head, Operational Intelligence and Innovation
    Genentech, A Member of the Roche Group, United States
  • Roger  Nosal
    Roger Nosal Vice President and Head, Global CMC
    Pfizer Inc, United States
  • Christine  Pierre, RN
    Christine Pierre, RN President
    Society for Clinical Research Sites, United States
  • Sarah  Pope Miksinski, PhD
    Sarah Pope Miksinski, PhD Dir., Off. of New Drug Products; Dir. (Acting), Off. of Surveillance, OPQ/CDER
    FDA, United States
  • Kim M. Quaintance-Lunn
    Kim M. Quaintance-Lunn VP and Head, US Regulatory Policy
    Bayer US LLC, United States
  • Badri  Rengarajan, MD
    Badri Rengarajan, MD Medical Affairs Lead, ASPIRE Unit
    Actelion, United States
  • Margaret S. Richards, PhD, MPH
    Margaret S. Richards, PhD, MPH Vice President, Data Analytics and Epidemiology, RW Stratey and Analytics
    Mapi Group, United States
  • Mitra  Rocca, MSc
    Mitra Rocca, MSc Associate Director, Medical Informatics, Office of Translational Science, CDER
    FDA, United States
  • Matthew D. Rotelli, PhD
    Matthew D. Rotelli, PhD Director, Global PK/PD and Pharmacometrics
    Eli Lilly and Company, United States
  • Leslie M. Sam
    Leslie M. Sam Director, Global Quality Systems, Safety, Efficacy and Customer Information
    Eli Lilly and Company, United States
  • David H. Schubert
    David H. Schubert Vice President of Regulatory and Quality
    Stealth BioTherapeutics, United States
  • Leigh  Shultz
    Leigh Shultz Associate Vice President, Project Management
    Merck & Co., Inc., United States
  • Ashley F. Slagle, PhD
    Ashley F. Slagle, PhD Principal, Scientific and Regulatory Consulting
    Aspen Consulting, LLC, United States
  • Nancy Pire Smerkanich, DrSc, MS
    Nancy Pire Smerkanich, DrSc, MS Assistant Professor, Clinical Pharmacy; Educational Liaison & Instructor, ICRS
    University of Southern California, United States
  • William B Smith, MD
    William B Smith, MD President
    New Orleans Center for Clinical Research, United States
  • Elizabeth  Somers, MSc, PMP
    Elizabeth Somers, MSc, PMP Director of Project Management, Global Project and Alliance Management
    Merck & Co., Inc., United States
  • Jeffrey N. Stuart
    Jeffrey N. Stuart Global Regulatory Director, Oncology, Immunology, and InVitro Diagnostics
    Merck & Co., Inc., United States
  • Ling  Su, PhD
    Ling Su, PhD Venture Partner
    Lilly Asia Ventures, China
  • Toshiyoshi  Tominaga, PhD
    Toshiyoshi Tominaga, PhD Associate Executive Director (for International Programs)
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Annette S. Williams, MBA, RPh
    Annette S. Williams, MBA, RPh Vice President, Lifecycle Safety
    QuintilesIMS, United States
Load More